权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Determination of the GIRK channel proteome

GIRK 通道蛋白质组的测定

基本信息

批准号：
9765512
负责人：
Paul A Slesinger
金额：
$ 25.43万
依托单位：
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
依托单位国家：
美国
项目类别：
财政年份：
2019
资助国家：
美国
起止时间：
2019-08-01 至 2021-07-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9765512
关键词：
Address Affect Affinity Chromatography Amino Acid Sequence Biochemical Biotin Biotinylation Brain Chimeric Proteins Cocaine Collaborations Complex DRD2 gene Data Dendrites Development Dopamine Endocytosis Engineering Enzymes Escherichia coli Excitatory Synapse Exhibits FDA approved G Protein-Coupled Receptor Signaling G-Protein-Coupled Receptors GIRK2 subunit, G protein-coupled inwardly-rectifying potassium channel GTP-Binding Proteins Goals Grant Inhibitory Synapse Ion Channel Knock-out Label Lead Modeling Mus Neurons Neurotransmitters Pathway interactions Pharmaceutical Preparations Pilot Projects Potassium Potassium Channel Preparation Protein Phosphatase 2A Regulatory Subunit PR53 Protein phosphatase Proteins Proteome Proteomics Psychostimulant dependence RGS Proteins Rewards Role Saline Set protein Signal Transduction Streptavidin Surface Synapses Synaptic Membranes System Techniques Time Validation Withdrawal addiction base cocaine exposure cocaine use density dopaminergic neuron drug of abuse experimental study gamma-Aminobutyric Acid genetic regulatory protein gephyrin high risk in vivo innovation inward rectifier potassium channel knock-down nanometer neuronal cell body neuronal excitability novel novel strategies novel therapeutics postsynaptic protein function protein transport psychostimulant receptor response tandem mass spectrometry trafficking treatment duration

项目摘要

Activation of G protein-gated inwardly rectifying potassium (GIRK) channels provides a key inhibitory signal in the brain that reduces neuronal firing. Many neurotransmitters in the reward pathway, such as dopamine and GABA, couple to GPCRs that signal through GIRK channels. Prior studies have established a role for GIRK channels in the response to psychostimulants. A complex network of proteins is hypothesized to support drug-dependent changes in trafficking and targeting of GIRK channels to postsynaptic inhibitory synapses, but the identity of these proteins remain largely unknown. To address this major gap in the field, an innovative technique of proximity-dependent biotin identification (referred to as iBio-ID) will be used to identify new proteins in the GIRK channel proteome (Aim 1). In this proposal, GIRK channels will be engineered to biotinylate proteins in vivo (within 50 nanometers of the channel), and then biotinylated proteins will be purified and identified using tandem mass spectrometry. Preliminary data show that GIRK channels fused to the biotinylating enzyme are functional, and can biotinylate proteins in vivo, leading to identification of putative GIRK channel regulators. Following quantitative analyses, candidate GIRK channel regulator proteins will be assessed for functional interaction with GIRK channels in neurons. Changes in the GIRK channel proteome with cocaine, using the locomotor sensitization as a model of addiction, will also be studied (Aim 2). These experiments will provide for the first time a comprehensive list of proteins in the GIRK channel proteome, and lead to the identity of new drug-dependent regulators of GIRK channels. Discovery of novel protein targets in the reward pathway could lead to the development of new treatments for addiction.

G蛋白门控内向整流钾（GIRK）通道的激活提供了一个关键的抑制性信号通路。减少神经元放电的信号。奖赏途径中的许多神经递质，如多巴胺和GABA与通过GIRK通道发出信号的GPCR偶联。先前的研究 GIRK通道在对精神兴奋剂的反应中发挥作用。蛋白质的复杂网络假设支持GIRK通道的贩运和靶向的药物依赖性变化，突触后抑制性突触，但这些蛋白质的身份仍然在很大程度上未知。解决该领域中的这一主要空白是一种邻近依赖性生物素鉴定的创新技术（参见作为iBio-ID）将用于鉴定GIRK通道蛋白质组（Aim 1）中的新蛋白质。在这一提议中， GIRK通道将被设计成在体内生物素化蛋白质（在通道的50纳米内），然后使用串联质谱法纯化和鉴定生物素化的蛋白质。初步数据显示，与生物素化酶融合的GIRK通道是功能性的，蛋白质在体内，导致推定的GIRK通道调节剂的鉴定。以下定量分析中，将评估候选GIRK通道调节蛋白的功能相互作用，神经元中的GIRK通道。可卡因引起的GIRK通道蛋白质组的变化，使用运动致敏作为成瘾模型，也将进行研究（目标2）。这些实验将为第一次在GIRK通道蛋白质组的蛋白质的全面列表，并导致新的身份 GIRK通道的药物依赖性调节剂。奖赏途径中新的蛋白质靶点的发现可能会导致新的成瘾治疗方法的发展。